| Date Filed | Type | Description |
| 10/06/2023 |
3
| Keese Kari Leigh (CFO) has filed a Form 3 on Axonics, Inc. |
| 10/04/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 10/03/2023 |
4
| Dearen Danny L. (President & CFO) has filed a Form 4 on Axonics, Inc.|
Txns:
| Sold 7,675 shares
@ $56.8717, valued at
$436.5k
Exercised 11,250 options to buy
@ $0 |
|
| 10/03/2023 |
4/A
| Dearen Danny L. (President & CFO) has filed a Form 4 on Axonics, Inc.|
Txns:
| Exercised 36,919 shares
@ $0
Sold 17,737 shares
@ $48.2103, valued at
$855.1k
Sold 947 shares
@ $49.0347, valued at
$46.4k
|
|
| 08/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/21/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/17/2023 |
4
| Ford Alfred J Jr (Chief Commercial Officer) has filed a Form 4 on Axonics, Inc.|
Txns:
| Sold 14,769 shares
@ $62.3381, valued at
$920.7k
|
|
| 08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/08/2023 |
4
| CARREL MICHAEL H (Director) has filed a Form 4 on Axonics, Inc.|
Txns:
| Gifted 500 shares
@ $0 |
|
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/31/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/28/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/27/2023 |
8-K
| Quarterly results |
| 06/28/2023 |
4
| Demski David M (Director) has filed a Form 4 on Axonics, Inc.|
Txns:
| Granted 3,000 shares
@ $0 |
|
| 06/28/2023 |
4
| Lopez Esteban (Director) has filed a Form 4 on Axonics, Inc.|
Txns:
| Granted 3,000 shares
@ $0 |
|
| 06/28/2023 |
4
| Kiernan Jane E (Director) has filed a Form 4 on Axonics, Inc.|
Txns:
| Granted 3,000 shares
@ $0 |
|
| 06/28/2023 |
4
| snyderman nancy lynn MD (Director) has filed a Form 4 on Axonics, Inc.|
Txns:
| Granted 3,000 shares
@ $0 |
|
| 06/28/2023 |
4
| CARREL MICHAEL H (Director) has filed a Form 4 on Axonics, Inc.|
Txns:
| Granted 3,000 shares
@ $0 |
|
| 06/28/2023 |
4
| McNamara Robert (Director) has filed a Form 4 on Axonics, Inc.|
Txns:
| Granted 3,000 shares
@ $0 |
|
| 05/31/2023 |
4
| Dearen Danny L. (President & CFO) has filed a Form 4 on Axonics, Inc.|
Txns:
| Sold 7,699 shares
@ $49.4355, valued at
$380.6k
Sold 300 shares
@ $50.14, valued at
$15k
|
|
| 05/18/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 05/18/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 05/01/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 05/01/2023 |
8-K
| Quarterly results |
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/06/2023 |
8-K
| Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Ob... |
| 04/04/2023 |
4
| Dearen Danny L. (President & CFO) has filed a Form 4 on Axonics, Inc.|
Txns:
| Sold 7,198 shares
@ $54.8346, valued at
$394.7k
Sold 7,802 shares
@ $55.6785, valued at
$434.4k
Exercised 6,633 options to buy
@ $14.19, valued at
$94.1k
Exercised 5,468 options to buy
@ $25.82, valued at
$141.2k
Exercised 2,899 options to buy
@ $1.63, valued at
$4.7k
|
|
| 03/10/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 10.3% stake in Axonics Inc. |
| 03/07/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 03/01/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/01/2023 |
8-K
| Quarterly results |
| 02/23/2023 |
4
| Sama Rinda (COO) has filed a Form 4 on Axonics, Inc.|
Txns:
| Sold 16,229 shares
@ $56.176, valued at
$911.7k
Sold 3,700 shares
@ $56.685, valued at
$209.7k
Sold 3,392 shares
@ $56.53, valued at
$191.7k
|
|
|